MLICM
IMUX icon

Metropolitan Life Insurance Company (MetLife)’s Immunic IMUX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-139
Closed -$15.7K – 2398
2022
Q1 		$15.7K Buy
+139
New +$16.1K ﹤0.01% 2194
2016
Q2 		– Sell
-42
Closed -$152K – 2681
2016
Q1 		$152K Hold
42
– – ﹤0.01% 2335
2015
Q4 		$193K Buy
+42
New +$137K ﹤0.01% 2290
2015
Q3 		– Sell
-32
Closed -$266K – 2689
2015
Q2 		$266K Buy
+32
New +$305K ﹤0.01% 2206

Other funds holding IMUX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s IMUX Position: Q2 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Immunic (IMUX) in Q2 2022, closing a stake of 139 shares — an estimated $15.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in IMUX in Q2 2015 and held it in 4 quarters. The position peaked at $266K in Q2 2015. 72 funds tracked by Wall St. Rank hold IMUX as of Q2 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Immunic position as of Q2 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 139 Immunic shares in Q2 2022, an estimated $15.7K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Immunic in Q2 2015 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Immunic position peaked at $266K in Q2 2015.
  • 72 funds tracked by Wall St. Rank held Immunic as of Q2 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.